Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dermacyd Femina to prevent bacterial vaginosis recurrence
NCT00556179Phase 4Completed
- Sponsor
- Sanofi
- Start
- Sep 2007
- Primary completion
- Dec 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lactoserum in bacterial vaginosis (BV), sponsored by Sanofi. Primary endpoint: Rate of recurrence of bacterial vaginosis at 3 months. Started Sep 2007; status: completed.
02
Drugs
lactoserum
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT00556179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00556179.